In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients - Wikidata - awgldk - TriplyDB

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients

http://www.wikidata.org/entity/Q33935142

about

Association of HLA-alleles with the immune regulation of chronic viral infections Developing Combined HIV Vaccine Strategies for a Functional Cure Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Establishment and Maintenance of the Human Naïve CD4+ T-Cell Compartment Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection.Trial watch: Immunostimulatory cytokines in cancer therapy.Regulatory T cells in HIV immunotherapy CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART Protective HIV-specific CD8+ T cells evade Treg cell suppression.Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development Low-dose IL-2 for In vivo expansion of CD4+ and CD8+ regulatory T cells in nonhuman primates SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment.Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.Regulatory T cells in HIV infection: can immunotherapy regulate the regulator?Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients.The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.Immunosenescence and hurdles in the clinical management of older HIV-patients.Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7 Negative modulation of suppressive HIV-specific regulatory T cells by IL-2 adjuvanted therapeutic vaccine.IL-2 immunotherapy in chronically SIV-infected Rhesus macaques.Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells.Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature.[Deficiency of HIV-specific T cell responses: are the Treg guilty?]Regulatory T cells (Tregs): A major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines.

P2860

Q26823033-D5BA7A76-2099-457F-92BF-05F7290C66F1 Q26998898-F4F36B3A-97C8-4167-9E3E-91BF8C714497 Q28078726-8B872684-8563-4562-AC5D-ACE30BB375E8 Q28080000-BFD340A1-E161-427D-85BD-C20F90243312 Q33650035-44219171-BF25-42A6-8CA4-0C94B83E5A73 Q33880165-729EF632-7FD5-44F2-8351-F47D6C702607 Q34725547-D27C8ECD-201B-4E7E-8C64-3FE30F902E75 Q34841938-F3696B42-B080-4BCF-AF2E-F9855DE5BF0A Q35122276-4477505D-F388-4EE0-B0E2-5AE8F9EC0BDC Q35626699-DA9BD232-D816-4235-B7EA-43A5F16AD9F6 Q35885111-2417F097-D432-4CA1-9ADE-9C87E472292F Q36053935-DE2BF7D0-8798-4914-BBD7-52F1A8B2234E Q36057482-CF9931F9-42D6-44D7-AAF3-3EDD0DA0A51A Q36142227-DEB79211-81CB-47EB-9BA6-03BC13DB7740 Q36162133-3FB8B0C0-B8F6-4635-A7E7-451EB96F61DA Q36195283-484260D3-C00D-4D07-896B-9BD460601B83 Q36462335-EF2869E7-0AEA-4AE9-96E4-AEEC868F28DF Q36956269-A08E6365-1D35-4211-A145-D479C0A06AE9 Q37054806-0930C715-1369-4E1C-A1EA-C096F487FB84 Q37548495-54750973-BE22-435C-8760-9E9616D00E2A Q37620568-CEAD1DED-3BC8-418C-B032-14B10218ADD1 Q37862747-444FE9F4-BBA2-43D3-9422-905C42D0DCCE Q37989867-FBC6A643-33E4-498D-A881-58963E237956 Q38059499-C6A3DD4E-50B5-48C4-B332-F420DAB96608 Q38068406-A5B2B4D8-62B2-4E14-84E7-F52AE85CCCD1 Q38164430-046D0293-3300-438B-80C9-AE8B35643CFE Q38424758-E27FCA42-841E-4A91-B509-030B81180A16 Q39170367-6A2270C2-A9CA-4A39-8975-E90E04C7B687 Q39972202-F5316DA8-C37B-497B-8744-6BE1546767A5 Q40122658-CD5729F8-B7E6-4B6B-B391-99135D9D5BDF Q41117681-A24C4DE2-5523-4786-A407-5FE923D7D0BE Q42157400-7CDBF663-594E-4A89-9265-695F34B1B9AA Q42248755-51E09106-E980-43F2-BB2C-E106706BFCE1 Q42251342-370F5AEA-8461-44CC-851B-CAA8F694C291 Q43117942-20654CAA-E781-4F31-ACFB-CE9A50904494 Q45362664-D90945BF-7028-4558-9626-79B988867D43 Q46122123-83871D7B-4FEF-47D3-A886-D7D60CC88C6A Q47170671-D1FA0D1B-C14F-4D9E-A0C4-F462BCDB58D2 Q49845916-36BF5FD0-B672-4F19-8ADA-ADC66FA0332F Q50424105-03C5C77A-155D-43F8-9632-9A8AEED2DA48

P2860

In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients

http://www.wikidata.org/entity/Q33935142

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@ast

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@en

type

label

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@ast

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@en

prefLabel

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@ast

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@en

P1433

Q33935142-F260B70F-A635-45B0-8392-DF50C9048304

P1476

Q33935142-948472B7-6985-4C20-A5C1-FDCCD5D1850E

P2093

Q33935142-2007B175-ECC0-4A71-8980-D8191837EC54

Q33935142-2E2FDC43-6813-43B7-8086-7984B5BC8C90

Q33935142-453418DA-69AE-4F1D-8CA7-126BE78AE336

Q33935142-589172EB-F37C-443F-9130-14899C05C172

Q33935142-6404D350-9682-489F-B812-EFE9F88CF7ED

Q33935142-64FF9CEB-5D3F-4151-AB33-ED4AB7D8E06A

Q33935142-961E8031-26B0-4B50-9C4E-C197323AA80D

Q33935142-E614C9B4-17E6-4C1C-B4D4-EACF5F1642A6

Q33935142-F6F1F2B4-4011-4DD2-B602-8F1E2995246D

P2860

Q33935142-024B940E-F335-4144-AD0F-E96631F217EF

Q33935142-02DE05BC-725E-476C-80B5-98962FE652B2

Q33935142-0B68A40E-5C6D-46C6-AE35-D451A5E69135

Q33935142-1E0550AB-C260-4FBF-855E-0C94CD4FC3EB

Q33935142-287BCDD6-2C82-4A32-91F6-843AA73F7392

Q33935142-30FFFD01-6E77-4ABE-A2D4-BA81B5D175F6

Q33935142-46709A0A-7892-4C03-98F2-A468B837BDA6

Q33935142-656DC666-93E4-4DE0-8ECC-C75C569F9520

Q33935142-74E692BC-8783-41B3-BFB1-AC6FC7FCB198

Q33935142-78F37DB9-E87D-4D35-8B3A-D709922FC969

P304

Q33935142-A70043CF-2DD5-4CB7-A329-AF5C6F4FA03E

P31

Q33935142-0ED32F90-299F-4D29-8F34-C126D879A328

P356

Q33935142-F8CCFA99-4904-40F9-BDBD-C920A1F42791

P407

Q33935142-6C585184-888F-4EF3-9A15-4FF09DB403BD

P433

Q33935142-86BD5167-3472-4550-AE08-6A391AA77285

P478

Q33935142-A15150B7-1C78-42FE-B4B8-8A3550637CF1

P577

Q33935142-C5B0F7D9-E71E-4E3E-B4DC-2DB50792DFC0

P5875

Q33935142-F0325961-5011-457E-BEA5-8187FB9B06DD

P698

Q33935142-5DBFE56B-EE94-4721-B8BE-981DCD541B12

P932

Q33935142-9E929831-7C06-4C74-8015-8C8CEE4EEC60

P356

PNAS.1000027107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

In vivo expansion of naive and ...... rleukin-2-treated HIV patients

@en

P2093

Arndt Benecke

http://www.w3.org/2001/XMLSchema#string

Brice Targat

http://www.w3.org/2001/XMLSchema#string

Fabrice A Letimier

http://www.w3.org/2001/XMLSchema#string

Lars Rogge

http://www.w3.org/2001/XMLSchema#string

Laurence Weiss

http://www.w3.org/2001/XMLSchema#string

Matthieu Carriere

http://www.w3.org/2001/XMLSchema#string

Sylvie Maiella

http://www.w3.org/2001/XMLSchema#string

Vladimira Donkova-Petrini

http://www.w3.org/2001/XMLSchema#string

Yves Levy

http://www.w3.org/2001/XMLSchema#string

P2860

Transcript imaging of the development of human T helper cells using oligonucleotide arrays

miR-181a is an intrinsic modulator of T cell sensitivity and selection

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Mechanisms of foxp3+ T regulatory cell-mediated suppression

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

CTLA-4 control over Foxp3+ regulatory T cell function

In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients

Interleukin-2 therapy in patients with HIV infection.

A peripheral circulating compartment of natural naive CD4 Tregs

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.

P304

10632-10637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1000027107

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44626091

http://www.w3.org/2001/XMLSchema#string

P698

20498045

http://www.w3.org/2001/XMLSchema#string

P932

2890853

http://www.w3.org/2001/XMLSchema#string